View in EDS HTML Full Text PDF Full Text

Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.

Saved in:
Bibliographic Details
Title: Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.
Authors: Marcus, Paula1 (AUTHOR), Warrington, Jenny1 (AUTHOR) jenny.warrington@uhn.ca, Zhang, Michael1 (AUTHOR), Ankathatti-Munegowda, Manjunatha1 (AUTHOR), Wang, Xing-Hua1 (AUTHOR), Rashedi, Iran1 (AUTHOR), Keating, Armand1,2 (AUTHOR)
Source: PLoS ONE. 4/20/2026, Vol. 21 Issue 4, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0347095